Clinical Trials of Orphan Drugs for Cancer

被引：2
|
作者：
Saltonstall, Peter L. [1 ]
机构：
[1] Natl Org Rare Disorders, Danbury, CT USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2011年 / 306卷 / 14期
关键词：
D O I：
10.1001/jama.2011.1463
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1545 / 1545
页数：1
相关论文
共 50 条
  • [1] Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer
    Kesselheim, Aaron S.
    Myers, Jessica A.
    Avorn, Jerry
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2320 - 2326
  • [2] Partial orphan cancer drugs: FDA approval, clinical benefit, trials, epidemiology, price, beneficiaries, and spending
    Michaeli, D. T.
    Michaeli, C. T.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S927 - S927
  • [3] Clinical trials of orphan medicines
    Buckley, Brendan M.
    [J]. LANCET, 2008, 371 (9629): : 2051 - 2055
  • [4] Partial Orphan Cancer Drugs: US Food and Drug Administration Approval, Clinical Benefit, Trials, Epidemiology, Price, Beneficiaries, and Spending
    Michaeli, Thomas
    Michaeli, Daniel Tobias
    [J]. VALUE IN HEALTH, 2024, 27 (04) : 449 - 457
  • [5] Clinical trials of orphan drugs in China over the decade 2012-2022: Opportunities and challenges
    Wu, Xiaofei
    Xu, Wen
    Yu, Mengyang
    Zhang, Fan
    Wang, Hongyun
    [J]. PHARMACOLOGICAL RESEARCH, 2022, 182
  • [6] Regulatory Considerations for Developing Drugs for Rare Diseases: Orphan Designations and Early Phase Clinical Trials
    Pariser, Anne R.
    Xu, Kui
    Milto, John
    Cote, Timothy R.
    [J]. DISCOVERY MEDICINE, 2011, 11 (59) : 367 - 375
  • [7] Orphandev, French Clinical Trials Network dedicated to Orphan drugs and therapeutics development for rare diseases
    Yolande Adjibi
    Joëlle Micallef
    Olivier Blin
    [J]. Orphanet Journal of Rare Diseases, 5 (Suppl 1)
  • [8] Characteristics of clinical trials to support approval of orphan drugs for neurological disorders by the Japanese regulatory agency
    Nakamura, H.
    Takeda, S.
    Iwasaki, M.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 847 - 847
  • [9] Pancreatic Cancer: Recent Progress of Drugs in Clinical Trials
    Zhang, Zhiyi
    Song, Jie
    Xie, Cao
    Pan, Jun
    Lu, Weiyue
    Liu, Min
    [J]. AAPS JOURNAL, 2021, 23 (02):
  • [10] Clinical endpoints in trials of drugs for cancer: time for a rethink?
    Koopmans, PP
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2002, 324 (7350): : 1389 - 1391
12345